Y. Sherer

发表

Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients.

Y. Shoenfeld, M. Fritzler, Y. Sherer, 2004, Seminars in arthritis and rheumatism.

Rare Jatropha multifida intoxication in two children.

H. Bibi, Y. Sherer, E. Hay, 2000, The Journal of emergency medicine.

Y. Shoenfeld, Y. Sherer, T. Matthias, 2008, Clinical reviews in allergy & immunology.

Anti-idiotypes to Oxidized LDL Antibodies in Intravenous Immunoglobulin Preparations--Possible Immunomodulation of Atherosclerosis

Y. Shoenfeld, B. Gilburd, T. Koike, 2003, Autoimmunity.

Oral drug therapy for erectile dysfunction: overview and aeromedical implications.

Y. Sherer, B. Azaria, A. Grossman, 2004, Aviation, space, and environmental medicine.

CONTEMPORARY CHALLENGES IN AUTOIMMUNITY Exposure to Epstein–Barr Virus Infection Is Associated with Mild Systemic Lupus Erythematosus Disease

M. Boaz, Y. Shoenfeld, J. Anaya, 2009 .

Mechanisms of Disease: atherosclerosis in autoimmune diseases

Y. Shoenfeld, Y. Sherer, Yehuda Shoenfeld, 2006, Nature Clinical Practice Rheumatology.

Novel antiphospholipid antibodies in autoimmune bullous diseases.

L. Sagi, Y. Shoenfeld, Y. Sherer, 2014, Human antibodies.

Atherosclerosis in Autoimmune Rheumatic Diseases—Mechanisms and Clinical Findings

Y. Shoenfeld, Y. Sherer, H. Zinger, 2009, Clinical reviews in allergy & immunology.

Carotid artery intima–media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis

A. Simon, G. Chironi, Y. Shoenfeld, 2008, Rheumatology International.

Early Atherosclerosis and Autoantibodies to Heat‐Shock Proteins and Oxidized LDL in Systemic Sclerosis

M. Cerinic, M. Conforti, M. Ehrenfeld, 2007, Annals of the New York Academy of Sciences.

Immunomodulation of various autoimmune diseases by intravenous immunoglobulin.

Y. Shoenfeld, Y. Levy, Y. Sherer, 1999, Drugs of today.

Atherosclerosis as an infectious, inflammatory and autoimmune disease

Y. Shoenfeld, D. Harats, Y. Sherer, 2001 .

Immunomodulation for treatment and prevention of atherosclerosis.

Y. Shoenfeld, Y. Sherer, 2002, Autoimmunity reviews.

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

Y. Shoenfeld, B. Gilburd, Y. Sherer, 2003, Annals of the rheumatic diseases.

Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

M. Cerinic, Y. Shoenfeld, N. Ronda, 2005, Circulation.

Infectious antibodies in systemic lupus erythematosus patients

M. Boaz, Y. Shoenfeld, J. Anaya, 2009, Lupus.

Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.

Y. Shoenfeld, Y. Levy, Y. Sherer, 2008, The Israel Medical Association journal : IMAJ.

Scientific evidence of the therapeutic effects of dead sea treatments: a systematic review.

Y. Shoenfeld, Y. Sherer, S. Sukenik, 2012, Seminars in arthritis and rheumatism.

Intravenous immunoglobulin treatment of lupus nephritis.

L. Rauova, Y. Shoenfeld, Y. Levy, 2000, Seminars in arthritis and rheumatism.

Delivered by Ingenta to : unknown IP : 127 . 0 . 0 . 1 Wed , 24

Y. Sherer, B. Azaria, A. Grossman, 2005 .

Laparoscopic inguinal hernioplasty in aviators.

Y. Sherer, B. Azaria, A. Grossman, 2005, Aviation, space, and environmental medicine.

Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin

Y. Shoenfeld, Y. Levy, Y. Sherer, 2005, Annals of the New York Academy of Sciences.

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis

Y. Shoenfeld, B. Gilburd, Y. Sherer, 2005, Clinical & developmental immunology.

Antiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs

Y. Shoenfeld, M. Blank, Y. Sherer, 2017 .

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

C. Gordon, M. Petri, M. Ward, 2009, Annals of the rheumatic diseases.

Vaccination as an additional player in the mosaic of autoimmunity.

Y. Shoenfeld, Y. Sherer, A. Aharon-Maor, 2000, Clinical and experimental rheumatology.

Heat‐Shock Protein 65 Autoantibodies Are Differently Associated with Early Atherosclerosis in Rheumatoid Arthritis and in Healthy Subjects

Y. Shoenfeld, B. Gilburd, E. Bocci, 2007, Annals of the New York Academy of Sciences.

Early operative intervention is associated with better patient survival in patients with intracapsular femur fractures but not extracapsular fractures.

Y. Sherer, A. Sternheim, E. Steinberg, 2014, The Journal of arthroplasty.

Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides

Y. Shoenfeld, B. Gilburd, Y. Sherer, 2006, Current rheumatology reports.

The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008.

Y. Shoenfeld, Y. Levy, B. Gilburd, 2008, The Israel Medical Association journal : IMAJ.

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

Y. Shoenfeld, Y. Levy, B. Gilburd, 2008, The Israel Medical Association journal : IMAJ.

Prevalence of Antiphospholipid and Antioxidized Low‐Density Lipoprotein Antibodies in Rheumatoid Arthritis

A. Giordano, E. Mannarino, Y. Shoenfeld, 2005, Annals of the New York Academy of Sciences.

Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?

Y. Shoenfeld, Y. Sherer, 2003, Immunobiology.

Antiphospholipid Antibodies in Human and Murine Atherosclerosis

Y. Shoenfeld, Y. Sherer, 2002 .

Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis

Y. Shoenfeld, Y. Sherer, 2001, Current atherosclerosis reports.

Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk?

M. Shechter, Y. Sherer, 2003, The Israel Medical Association journal : IMAJ.

Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water

Y. Shoenfeld, D. Harats, A. Shaish, 2007, Biological Trace Element Research.

Suppression of Atherogenesis in Female Low-Density Lipoprotein Receptor Knockout Mice following Magnesium Fortification of Drinking Water: The Importance of Diet

Y. Shoenfeld, D. Harats, A. Shaish, 2000, Pathobiology.

Magnesium Fortification of Drinking Water Suppresses Atherogenesis in Male LDL-Receptor-Deficient Mice

Y. Shoenfeld, D. Harats, A. Shaish, 1999, Pathobiology.

Thromboembolic phenomena in patients with hereditary factor XI deficiency.

Y. Shoenfeld, Y. Levy, Y. Sherer, 1998, Annales de medecine interne.

A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response

Y. Shoenfeld, Y. Levy, J. George, 1999, Lupus.

Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin

Y. Shoenfeld, Y. Levy, Y. Sherer, 1999, Lupus.

The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease.

Y. Shoenfeld, M. Feinberg, M. Shechter, 2007, The Israel Medical Association journal : IMAJ.

Autoimmune diseases and autoimmunity post-bone marrow transplantation

Y. Shoenfeld, Y. Sherer, 1998, Bone Marrow Transplantation.

Autoantibodies to Cardiolipin and Beta-2-Glycoprotein-I in Coronary Artery Disease Patients with and without Hypertension

A. Tenenbaum, E. Fisman, M. Motro, 2002, Cardiology.

A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.

E. Klang, Y. Shoenfeld, Y. Sherer, 2015, Autoimmunity reviews.

Impact in total ischemic time and ST-segment elevation myocardial infarction admissions during COVID-19

C. Yosefy, Y. Sherer, Azriel B. Osherov, 2021, The American Journal of Emergency Medicine.

Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies

Y. Shoenfeld, B. Gilburd, P. Youinou, 2001, Autoimmunity.

Dermatomyositis and polymyositis associated with the antiphospholipid syndrome—a novel overlap syndrome

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Lupus.

Stem cells transplantation–a cure for autoimmune diseases

Y. Shoenfeld, Y. Sherer, 1998, Lupus.

Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

Y. Shoenfeld, Y. Sherer, 2006, Autoimmunity reviews.

Antiphospholipid syndrome in pregnancy--animal models and clinical implications.

Y. Shoenfeld, Y. Sherer, M. Blank, 1998, Scandinavian journal of rheumatology. Supplement.

Immune tolerance as a strategy for treatment of atherosclerosis

Y. Shoenfeld, B. Gilburd, Y. Sherer, 2005 .

Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins

Y. Shoenfeld, B. Gilburd, M. Blank, 2002, European journal of immunology.

Tobacco smoking and autoimmune rheumatic diseases

Y. Shoenfeld, Y. Sherer, M. Harel-Meir, 2007, Nature Clinical Practice Rheumatology.

Atherosclerosis: Evidence for the Role of Autoimmunity

Y. Shoenfeld, J. George, D. Harats, 2001 .

Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease.

Y. Shoenfeld, B. Gilburd, M. Shechter, 2008, The American journal of cardiology.

Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature.

Y. Shoenfeld, Y. Bar-dayan, Y. Levy, 1998, Seminars in arthritis and rheumatism.

Epstein–Barr Virus and Cytomegalovirus in Autoimmune Diseases

Y. Shoenfeld, J. Anaya, Y. Sherer, 2007, Annals of the New York Academy of Sciences.

Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin

Y. Shoenfeld, Y. Bar-dayan, Y. Levy, 1999, International Archives of Allergy and Immunology.

The Dual Relationship Between Thymectomy and Autoimmunity

Y. Shoenfeld, Y. Bar-dayan, Y. Sherer, 1999 .

The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity.

Y. Shoenfeld, M. Harel, M. Blank, 2005, Immunobiology.

Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis

Y. Shoenfeld, E. Bocci, Y. Sherer, 2007, Annals of the rheumatic diseases.

Bacterial triggers and autoimmune rheumatic diseases.

Y. Shoenfeld, H. Zeidler, L. Guilherme, 2008, Clinical and experimental rheumatology.

Functional class in patients with heart failure is associated with the development of diabetes.

A. Tenenbaum, E. Fisman, M. Motro, 2003, The American journal of medicine.

Atherosclerosis

Y. Shoenfeld, Y. Sherer, 2002 .

Assessment of Predictors for SARS-CoV-2 Antibodies Decline Rate in Health Care Workers after BNT162b2 Vaccination—Results from a Serological Survey

Y. Sherer, S. Maayan, N. Bilenko, 2022, Vaccines.

Brucellosis outbreak: analysis of risk factors and serologic screening.

Y. Sherer, J. Mishal, Y. Levin, 1999, International journal of molecular medicine.

Intravenous immunoglobulin therapy of antiphospholipid syndrome.

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Rheumatology.

Outcome of patients having dermatomyositis admitted to the intensive care unit

M. Ehrenfeld, Y. Shoenfeld, Y. Levy, 2007, Clinical Rheumatology.

Autoantibody explosion in antiphospholipid syndrome.

Y. Shoenfeld, Y. Sherer, G. Twig, 2008, Journal of autoimmunity.

Systemic Involvement in the Antiphospholipid Syndrome

Y. Shoenfeld, M. Blank, Y. Sherer, 2002 .

Induction and treatment of the antiphospholipid syndrome – lessons from animal models

Y. Shoenfeld, Y. Sherer, M. Blank, 2001, European journal of clinical investigation.

Anti-Prothrombin Antibodies in Thrombosis and Atherosclerosis

Y. Shoenfeld, D. Harats, M. Blank, 2001 .

Arrhythmogenic right ventricular dysplasia: a possible cause of sudden incapacitation.

Y. Sherer, B. Azaria, A. Grossman, 2004, Aviation, space, and environmental medicine.

Low levels of heat shock proteins-60 and -65 autoantibodies in Sjögren's syndrome.

Y. Shoenfeld, E. Bocci, Y. Sherer, 2005, The Israel Medical Association journal : IMAJ.

Marked Improvement of Severe Cardiac Dysfunction After One Course of Intravenous Immunoglobulin in a Patient with Systemic Lupus Erythematosus

Y. Shoenfeld, Y. Levy, Y. Sherer, 1999, Clinical Rheumatology.

Novel Perspectives in the Treatment of the Antiphospholipid Syndrome —From Anticoagulation to Immunomodulation

Y. Shoenfeld, M. Blank, Y. Sherer, 2002 .

Immunomodulation of experimental antiphospholipid syndrome.

Y. Shoenfeld, Y. Sherer, M. Blank, 1998, Scandinavian journal of rheumatology. Supplement.

Acute cerebellar vertigo in a fighter pilot.

Y. Sherer, B. Azaria, A. Grossman, 2004, Aviation, space, and environmental medicine.

The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis

Y. Shoenfeld, Y. Sherer, J. Freire de Carvalho, 2007, Thrombosis and Haemostasis.

Safety of intravenous immunoglobulin (IVIG) therapy.

A. Achiron, Y. Shoenfeld, Y. Sherer, 2007, Autoimmunity reviews.

Intravenous immunoglobulin

Y. Shoenfeld, Y. Sherer, U. Katz, 2005, Clinical reviews in allergy & immunology.

Autoantibodies associated with atherosclerosis.

Y. Shoenfeld, J. George, D. Harats, 2000, Annals of medicine.

Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model

Y. Shoenfeld, M. Blank, Y. Sherer, 2003, Lupus.

Antiphospholipid syndrome: insights from animal models

Y. Shoenfeld, Y. Sherer, 2000, Current opinion in hematology.

Thymoma and Autoimmune Diseases

Y. Shoenfeld, Y. Sherer, 2000 .

The Antiphospholipid (Hughes') Syndrome: An Entity to Be Expanded

Y. Shoenfeld, Y. Sherer, 1999, American journal of reproductive immunology.

Idiotypic network dysregulation

Y. Shoenfeld, Y. Sherer, 2000, Applied biochemistry and biotechnology.

Common infectious agents prevalence in antiphospholipid syndrome

Y. Shoenfeld, N. Agmon-Levin, R. Cervera, 2009, Lupus.

Chapter 11 Antiphospholipid Antibodies, Infections, and Drugs

Y. Shoenfeld, M. Blank, Y. Sherer, 2009 .

Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases (Review).

Y. Shoenfeld, Y. Sherer, Y. Bardayan, 1997, International journal of oncology.

Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature.

L. Sagi, Y. Shoenfeld, N. Agmon-Levin, 2011, Autoimmunity reviews.

The changing face of Lemierre's syndrome.

Y. Sherer, J. Mishal, 2003, The Israel Medical Association journal : IMAJ.

Early antibiotic treatment may prevent complete development of Lemierre's syndrome: experience from 2 cases.

Y. Sherer, J. Mishal, O. Leibovici, 2000, Scandinavian journal of infectious diseases.

Successful Treatment of Systemic Lupus Erythematosus Cerebritis with Intravenous Immunoglobulin

Y. Shoenfeld, Y. Levy, Y. Sherer, 1999, Clinical Rheumatology.

A malignancy work-up in patients with cancer-associated (paraneoplastic) autoimmune diseases: pemphigus and myasthenic syndromes as cases in point (review).

Y. Shoenfeld, Y. Sherer, 1999, Oncology reports.

Pemphigus and infectious agents.

L. Sagi, Y. Shoenfeld, Y. Sherer, 2008, Autoimmunity reviews.

Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases

L. Rauova, Y. Shoenfeld, Y. Levy, 2001, Pharmacology.

Skin Score Decrease in Systemic Sclerosis Patients Treated with Intravenous Immunoglobulin – A Preliminary Report

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Clinical Rheumatology.

INTRAVENOUS IMMUNOGLOBULIN ( IVIg ) IN AUTOIMMUNE DISEASES – EXPANDING INDICATIONS AND INCREASING SPECIFICITY

Y. Shoenfeld, Y. Levy, Y. Sherer, 2003 .

Cytokine levels in various intravenous immunoglobulin (IVIg) preparations.

Y. Shoenfeld, Y. Levy, Y. Sherer, 2001, Human antibodies.

Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis

Y. Shoenfeld, Y. Levy, Y. Sherer, 2003, Annals of the rheumatic diseases.

IVIG in autoimmunity and cancer – efficacy versus safety

Y. Shoenfeld, Y. Levy, Y. Sherer, 2002, Expert opinion on drug safety.

Detection of Antibodies to Gangliosides and Glycolipids in Various Intravenous Immunoglobulin (IVIg) Preparations

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Immunological investigations.

A latitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia.

Y. Shoenfeld, J. Anaya, M. Blank, 2008, The Israel Medical Association journal : IMAJ.

Matrix Metalloproteinase-9 and Autoimmune Diseases

Maya Ram, Y. Shoenfeld, Y. Sherer, 2006, Journal of Clinical Immunology.

The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice.

Y. Shoenfeld, Y. Levy, M. Blank, 2003, Human reproduction.

In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations – a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases *

Y. Shoenfeld, Y. Sherer, J. Peter, 2002, Transfusion medicine.

Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology.

Y. Shoenfeld, Y. Sherer, N. Bizzaro, 2008, Autoimmunity reviews.

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

I. Mackay, Y. Shoenfeld, B. Gilburd, 2008, The Israel Medical Association journal : IMAJ.

[Epidermoid cyst of the spleen].

Y. Sherer, A. Halevy, H. Manor, 1998, Harefuah.

Transverse Myelitis in Patients with Antiphospholipid Antibodies – The Importance of Early Diagnosis and Treatment

Y. Shoenfeld, Y. Levy, Y. Sherer, 2002, Clinical Rheumatology.

Survival without surgical repair of acute rupture of the right ventricular free wall

Y. Shoenfeld, E. Konen, Y. Levy, 1999, Clinical cardiology.

Inflammation and accelerated atherosclerosis: basic mechanisms.

Y. Shoenfeld, Y. Sherer, A. Doria, 2005, Rheumatic diseases clinics of North America.

Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS.

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Clinical and experimental rheumatology.

Anti-cardiolipin antibody from a patient with antiphospholipid syndrome ( APS ) recognizes only an epitope expressed by cardio-lipin / 2-glycoprotein-I ( 2 GPI ) complex and induces APS

Y. Shoenfeld, Y. Levy, Y. Sherer, 2006 .

The Idiotypic Network in Antinuclear-Antibody-Associated Diseases

Y. Shoenfeld, Y. Sherer, 2000, International Archives of Allergy and Immunology.

Physical Examination and ECG Screening in Relation to Echocardiography Findings in Young Healthy Adults

D. Landau, Y. Sherer, D. Carter, 2007, The Cardiology.

The Effect of Renin-Angiotensin Axis Inhibition on Early Atherogenesis in LDL-Receptor-Deficient Mice

Y. Sharabi, D. Harats, A. Shaish, 2001, Pathobiology.

Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".

M G Danieli, G Pucci, Ricard Cervera, 2006, Autoimmunity reviews.

Huge Renal Arteriovenous Malformation Mimicking a Simple Para-Pelvic Cyst

Y. Sherer, D. London, J. Mishal, 2001, Urologia Internationalis.

Huge renal arteriovenous malformation mimicking simple parapelvic cyst.

Y. Sherer, D. London, J. Mishal, 2000, Clinical imaging.

Use of intravenous immunoglobulin in idiopathic membranous nephropathy.

Y. Shoenfeld, Y. Levy, J. George, 1999, Internal medicine.

Interleukin-3 and pregnancy loss in antiphospholipid syndrome.

P. Fishman, Y. Shoenfeld, Y. Sherer, 1998, Scandinavian journal of rheumatology. Supplement.

Precocious Atherosclerosis in Rheumatoid Arthritis

Y. Shoenfeld, E. Bocci, Y. Sherer, 2007, Annals of the New York Academy of Sciences.

Atherosclerosis in systemic lupus erythematosus

Y. Shoenfeld, Y. Sherer, Hasia Zinger, 2010, Autoimmunity.

Comparative clinical study of cefonicid, chloramphenicol, and penicillin in community-acquired pneumonia.

Y. Shoenfeld, Y. Levy, Y. Sherer, 1998, International journal of molecular medicine.

Hyponatremia induced by amiodarone therapy.

Y. Sherer, E. Shavit, 2007, The Israel Medical Association journal : IMAJ.

Autoantibodies to oxidized low-density lipoprotein in coronary artery disease.

A. Tenenbaum, E. Fisman, M. Motro, 2001, American journal of hypertension.

Aortic valve calcification in hypertensive patients: prevalence, risk factors and association with transvalvular flow velocity.

E. Schwammenthal, A. Tenenbaum, E. Fisman, 2004, International journal of cardiology.

Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model.

Y. Shoenfeld, D. Harats, A. Shaish, 2001, Magnesium Research.

Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting.

Y. Sherer, J. Mishal, Y. Levin, 2001, Scandinavian journal of infectious diseases.

Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Rheumatology International.

Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies

A. Tenenbaum, E. Fisman, M. Motro, 2001, Cardiology.

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain.

A. Tenenbaum, M. Motro, Y. Shoenfeld, 2000, The American journal of cardiology.

Early Atherosclerosis in Rheumatoid Arthritis: Effects of Smoking on Thickness of the Carotid Artery Intima Media

A. Giordano, E. Mannarino, B. Gilburd, 2005, Annals of the New York Academy of Sciences.

Multiple Autoantibodies Associated with Autoimmune Reproductive Failure

Y. Shoenfeld, M. Blank, Y. Sherer, 2003, Journal of Assisted Reproduction and Genetics.

Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies

E. Mannarino, Y. Shoenfeld, B. Gilburd, 2007, Lupus.

Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.

Y. Shoenfeld, J. Anaya, Y. Sherer, 2015, The Israel Medical Association journal : IMAJ.

Antiphospholipid syndrome (APS): where does it come from?

Y. Shoenfeld, M. Blank, Y. Sherer, 2007, Best practice & research. Clinical rheumatology.

Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998.

Y. Shoenfeld, D. Alarcón-Segovia, T. Koike, 1999, Seminars in arthritis and rheumatism.

Frontiers in SLE: Review of the 5th International Congress of systemic Lupus Erythematosus.

Y. Shoenfeld, D. Alarcón-Segovia, T. Koike, 1999 .

The expanding world of autoimmunity.

Y. Shoenfeld, Y. Sherer, J. Kalden, 2002, Trends in immunology.

Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome

Y. Shoenfeld, Y. Levy, Y. Sherer, 2002, Annals of Hematology.

Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up

A. Tenenbaum, E. Fisman, M. Motro, 2004, European Journal of Cardiovascular Prevention & Rehabilitation.

Artherosclerosis as an infectious, inflammatory and autoimmune disease.

Y. Shoenfeld, D. Harats, Y. Sherer, 2001, Trends in immunology.

Fibrosis regression induced by intravenous gammaglobulin treatment

Y. Shoenfeld, Y. Bar-dayan, Y. Levy, 2003, Annals of the rheumatic diseases.

Transient polycythemia and multi-organ failure due to acute alcohol ingestion

Y. Sherer, J. Mishal, E. Magen, 2000, Annals of Hematology.

The maintenance of wakefulness test as a predictor of alertness in aircrew members with idiopathic hypersomnia.

Y. Sherer, B. Azaria, A. Grossman, 2004, Aviation, space, and environmental medicine.

10th International Congress on Antiphospholipid Antibodies--summary.

M. Ehrenfeld, Y. Shoenfeld, B. Gilburd, 2003, Autoimmunity Reviews.

Anti-phospholipid autoantibodies--do they have a pathogenic role in infertility?

Y. Shoenfeld, Y. Sherer, 1998, Scandinavian Journal of Rheumatology. Supplement.

Autoantibody Level Modification in Adult Patients with Idiopathic Thrombocytopenic Purpura following Intravenous Immunoglobulin Treatment

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Natural Immunity.

Lessons from the "Euro-Lupus Cohort".

C. Carcassi, L. Contu, J. Piette, 2002, Annales de medecine interne.

Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIg) - report of seven cases and review of the literature.

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, European journal of internal medicine.

Pemphigus and infectious agents.

L. Sagi, Y. Shoenfeld, Y. Sherer, 2008, Autoimmunity reviews.